x
Breaking News
0

Aurobindo Pharma Ltd. (ARBN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
665.00 -4.15    -0.62%
13:51:27 - Real-time Data. Currency in INR ( Disclaimer )
Type: Equity
Market: India
ISIN: INE406A01037 
S/N: AUROPHARMA
  • Volume: 1,264,217
  • Bid/Ask: 664.90 / 664.95
  • Day's Range: 660.50 - 676.95
Start Trading
Aurobindo Pharma 665.00 -4.15 -0.62%

ARBN Overview

 
Information about the Aurobindo Pharma Ltd. Share. You can find more details by going to one of the sections listed on this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close669.15
Day's Range660.5 - 676.95
Revenue156.62B
Open670.95
52 wk Range503.05 - 809.45
EPS41.17
Volume1,264,217
Market Cap392.04B
Dividend (Yield)0 (0.41%)
Average Volume (3m)2,543,571
P/E Ratio16.25
Beta0.82
1-Year Change - 6.88%
Shares Outstanding585,882,409
Next Earnings DateFeb 07, 2018
What is your sentiment on Aurobindo Pharma?
or
Vote to see community's results!

Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Sell Strong Sell Strong Sell Strong Sell Neutral
Technical Indicators Strong Sell Strong Sell Strong Sell Strong Sell Sell
Summary Strong Sell Strong Sell Strong Sell Strong Sell Neutral

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Engulfing Bearish 30 Current
Three Outside Down 1M Current
Completed Patterns
Engulfing Bearish 1M 1 Nov 17
Engulfing Bearish 15 1 Dec 14, 2017 13:30
Evening Doji Star 15 1 Dec 14, 2017 13:30

Aurobindo Pharma Ltd. News & Analysis

Aurobindo Pharma Ltd. Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NSE 665.00 664.90 664.95 1,264,217 -0.62% INR 13:51:27  
  NSE 666.25 0.00 0.00 3,111,200 -0.60% INR 13:51:00  
  BSE 664.00 663.75 664.40 119,605 -0.70% INR 13:35:00  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Tech Mahindra 512.80 518.15 503.00 +9.20 +1.83% 2.89M 13:51:17  
  Tata Communications 711.90 754.00 701.20 +15.50 +2.23% 6.06M 13:51:18  
  SBI 312.95 315.40 309.50 -0.35 -0.11% 9.03M 13:51:25  
  Vedanta 282.85 288.05 280.35 -0.70 -0.25% 5.66M 13:51:32  
  Tata Consultancy 2,545.80 2,632.00 2,531.10 -82.60 -3.14% 2.05M 13:51:20  
  Tata Motors 401.40 404.55 398.20 -0.55 -0.14% 3.26M 13:51:38  
  Wockhardt 752.15 760.00 723.95 +31.00 +4.30% 2.74M 13:51:17  
  Punjab National Bank 169.60 170.65 166.15 +1.80 +1.07% 9.32M 13:51:30  
  Ashok Leyland 111.90 114.80 111.10 -2.15 -1.89% 7.71M 13:51:12  
  Oil & Natural Gas 184.15 186.70 182.40 +0.25 +0.14% 3.81M 13:51:30  

Aurobindo Pharma Ltd. Company Profile

IndustryMajor Drugs
SectorHealthcare
Employees

13982

Equity Type

ORD

Aurobindo Pharma Limited is a pharmaceutical company. The Company is engaged in producing oral and injectable generic formulations and active pharmaceutical ingredients (APIs). Its product portfolio is spread over seven therapeutic/product areas, including antibiotics, anti-retrovirals, cardiovascular, central nervous system, gastroenterologicals, anti-allergies and anti-diabetics. It is engaged in developing a range of oncology and hormonal products. It is also developing inhalation and dermatology products, such as pressurized metered-dose inhaler (pMDI). It markets its products through chain stores in the United States. It has developed over three injectable penem products. The Company, through its subsidiary, manufactures and sells nutritional supplements. It has over 10 manufacturing units and approximately two research and development centers. The Company, in addition to marketing its products domestically, also markets its products globally in over 150 countries.

Read More

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

 
Are you sure you want to delete this chart?
 
Write your thoughts about Aurobindo Pharma Ltd.
 
Replace the attached chart with a new chart ?
Post
Post also to:
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Latest ARBN Comments

AKSHAT JOON
AKSHAT JOON Dec 04, 2017 12:50 GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Sharp upmove till 730
Reply
0 0
Keerthika Chandramohan
Keerthika Chandramohan Dec 05, 2017 14:46 GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
yes good chances for upmove.
Reply
0 0
sanket borole
sanket borole Nov 16, 2017 8:52 GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What is the tody try for buying
Reply
0 0
Stock market
stock2market Aug 24, 2017 4:30 GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
INTRA BUY AURO 705 SL698 TG715/730
Reply
0 0
Show more comments
 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post 1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email